FDA clears Boston Scientific endoscopic catheter

Justine Varieur Cadet | | Health Imaging | Screening
Boston Scientific has received 510(k) clearance from the FDA to market its SpyScope Access and Delivery catheter for diagnostic and therapeutic applications during endoscopic procedures of the pancreatico-biliary system.

The SpyScope catheter is used in conjunction with the SpyGlass Direct Visualization system, according to the Natick, Mass.-based company.

Previously available for use in the bile and hepatic ducts, the SpyGlass system can now be used to guide visualization and accessory devices throughout the pancreatico-biliary system, allow physicians to diagnose and treat pancreatic cancer or pre-cancerous tissues, Boston Scientific said.

Justine Varieur Cadet

Related Content

Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility
Breast cancer rates among women in their 30s are on the rise

Around the web

Radiology Business
Key Medicare reimbursement and No Surprises Act updates from RSNA 2024

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

Cardiovascular Business
Philips, Mayo Clinic using AI to improve cardiac MRI technology

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services.